Takeda Pharmaceutical
TAK
$13.22
Share price
-1.20%
Change (1 day)
-21.59%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Cash on Hand
Cash on Hand as of December 2023 : $2.25 B
According to Takeda Pharmaceutical's latest financial reports the company has $2.25 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $4.15 B | -42.03% |
| 2022-03-31 | $7.17 B | -21.12% |
| 2021-03-31 | $9.09 B | 50.31% |
| 2020-03-31 | $6.04 B | -7.45% |
| 2019-03-31 | $6.53 B | 85.19% |
| 2018-03-31 | $3.52 B | 4.87% |
| 2017-03-31 | $3.36 B | -32.48% |
| 2016-03-31 | $4.98 B | -16.16% |
| 2015-03-31 | $5.94 B | -28.13% |
| 2014-03-31 | $8.27 B | 38.81% |
| 2013-03-31 | $5.95 B | 7.23% |
| 2012-03-31 | $5.55 B | -47.14% |
| 2011-03-31 | $10.51 B | 11.33% |
| 2010-03-31 | $9.44 B | 23.18% |
| 2009-03-31 | $7.66 B | -54.57% |
| 2008-03-31 | $16.87 B | 10.41% |
| 2007-03-31 | $15.28 B | -3.72% |
| 2006-03-31 | $15.87 B | 11.75% |
| 2005-03-31 | $14.20 B | 12.35% |
| 2004-03-31 | $12.64 B | 30.74% |
| 2003-03-31 | $9.67 B | 45.49% |
| 2002-03-31 | $6.64 B | 16.37% |
| 2001-03-31 | $5.71 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 918.14% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 520.02% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 463.53% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 386.00% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 340.89% | 🇫🇷 France |
 Merck MRK | $7.09 B | 214.98% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 182.20% | 🇬🇧 UK |
 Seagen
SGEN | $1.23 B | -45.07% | 🇺🇸 USA |
 Dr. Reddy's RDY | $0.86 B | -61.40% | 🇮🇳 India |